As one of the most incurable and therefore deadliest diseases that ever affected humans, cancer serves as a longstanding challenge for all the people in the medical and research fields. Thus, it is no wonder that a scientist as brilliant as Mikhail Blagosklonny joined in the wagon not too long ago and came up with theories on how to stop aging as well as cancer.
The doctor and professor attended the First Pavlov State Medical University of St. Peterburg, a well-known institution in Russia with no less than 100 years of history. Mikhail Blagosklonny spent a good portion of his life in this place, for he received a Medicinae Doctor degree with a specialty in internal medicine there, and then continued to obtain a Ph.D. in cardiology and experimental medicine.
Some time after his graduation, in 2002, Blagosklonny uprooted himself from the Soviet and moved to the United States, particularly in New York, to become an associate profession in New York Medical College situated within the hamlet of Valhalla in the same state. His stay in this academy, however, was short-lived as Mikhail Blagosklonny transferred to the Ordway Research Institute in Albany to take on the senior scientist post. He served this facility until 2009 before he accepted a position at the Roswell Park Research Insitute as a professor of oncology.
Mikhail Blagosklonny focuses his intellect and experimental skills at present in looking for treatments for cancer and aging that can offer long-term effectivity. His main concern is to find a cure that is capable of exterminating the infected cancer cells in the human body without killing the healthier cells along the process. Also, he wishes to understand how the current anti-aging medications function so as to turn up with a more efficient solution to the issue of getting old. See: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249451/
During the researches he conducted, he was able to hypothesize that the signaling of a particular enzyme within the system with the help of rapamycin, a widely acclaimed drug for cancer, can potentially allow the users to prolong their lives and prevent aging. How this works is that the mechanistic target of rapamycin will connect to various protein chains inside the body to create two unique protein complexes. These new chains can now imitate the behavior of another kinase called threonine or serine which has the role of managing cell proliferation, growth, survival, motility, and many others.
Read works by Mikhail Blagosklonny on Google Scholar